BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 4.930
+0.060 (1.23%)
Sep 4, 2026, 3:48 PM EST
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-2.61M CAD
Market Cap
42.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
BriaCell Therapeutics News
- 11 days ago - BriaCell (BCTX) Advances Melanoma Vaccine Development Amid Challenging Valuation Metrics - GuruFocus
- 11 days ago - BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+ - TheFly
- 11 days ago - BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ - GlobeNewsWire
- 4 weeks ago - BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer - TheFly
- 4 weeks ago - BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - GlobeNewsWire
- 7 weeks ago - BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
- 7 weeks ago - BriaCell announces Odette Cancer Centre joins Bria-IMT trial - TheFly
- 7 weeks ago - BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer - GlobeNewsWire